{"id":254812,"date":"2026-09-18T09:41:32","date_gmt":"2026-09-18T04:11:32","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=254812"},"modified":"2026-09-18T09:41:32","modified_gmt":"2026-09-18T04:11:32","slug":"gpt-healthcare-q2-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/gpt-healthcare-q2-results\/","title":{"rendered":"GPT Healthcare Q2 FY27 Preview: Trends and Numbers to Watch"},"content":{"rendered":"<p>Track the latest <a href=\"https:\/\/univest.in\/stocks\/gpthealth\/gpt-healthcare-ltd-share-price-today\">GPT Healthcare Ltd. share price<\/a> on Univest. With the September 2026 quarter nearing its end, hospital chain investors are turning attention to the GPT Healthcare Q2 results, the next earnings update for this Kolkata-headquartered healthcare operator. GPT Healthcare has shown a steady improvement in operating margin over the past five quarters even as revenue growth has moderated in the two most recent periods, and that combination frames expectations for the GPT Healthcare Q2 results.<\/p>\n<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;\"><em>Revenue held near Rs 126 Cr in Q1 FY27 versus Rs 107 Cr in Jun25. OPM improved to 19.05%. CMP Rs 163.61, PE 28.3x.<\/em><\/p>\n<p>This preview covers the expected announcement window, the metrics worth watching, actual numbers from the last two reported quarters, and the current valuation, based strictly on historical, publicly disclosed financials rather than any forecast figure.<\/p>\n<p style=\"margin-top:24px\"><a href=\"https:\/\/univest.in\/open-demat-account\">Ready to track this stock ahead of results? Open a free demat account with Univest.<\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/gpt-healthcare-q2-results\/#GPT_Healthcare_Q2_results_Date_When_Will_GPT_Healthcare_Announce_Q2_FY27_Numbers\" title=\"GPT Healthcare Q2 results Date: When Will GPT Healthcare Announce Q2 FY27 Numbers\">GPT Healthcare Q2 results Date: When Will GPT Healthcare Announce Q2 FY27 Numbers<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/gpt-healthcare-q2-results\/#GPT_Healthcare_Q2_results_Expectations_Metrics_and_Trends_to_Watch\" title=\"GPT Healthcare Q2 results Expectations: Metrics and Trends to Watch\">GPT Healthcare Q2 results Expectations: Metrics and Trends to Watch<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/gpt-healthcare-q2-results\/#GPT_Healthcare_Q1_FY27_Quarter_Ended_June_2026_Previous_Quarter_Actuals\" title=\"GPT Healthcare Q1 FY27 (Quarter Ended June 2026): Previous Quarter Actuals\">GPT Healthcare Q1 FY27 (Quarter Ended June 2026): Previous Quarter Actuals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/gpt-healthcare-q2-results\/#GPT_Healthcare_Q2_FY26_Quarter_Ended_September_2025_The_Base_Quarter\" title=\"GPT Healthcare Q2 FY26 (Quarter Ended September 2025): The Base Quarter\">GPT Healthcare Q2 FY26 (Quarter Ended September 2025): The Base Quarter<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/gpt-healthcare-q2-results\/#GPT_Healthcare_Q2_results_Recent_5-Quarter_Trend\" title=\"GPT Healthcare Q2 results: Recent 5-Quarter Trend\">GPT Healthcare Q2 results: Recent 5-Quarter Trend<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/gpt-healthcare-q2-results\/#Key_Factors_to_Watch_Ahead_of_the_GPT_Healthcare_Q2_results\" title=\"Key Factors to Watch Ahead of the GPT Healthcare Q2 results\">Key Factors to Watch Ahead of the GPT Healthcare Q2 results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/gpt-healthcare-q2-results\/#GPT_Healthcare_Valuation_Snapshot_Ahead_of_the_GPT_Healthcare_Q2_results\" title=\"GPT Healthcare Valuation Snapshot Ahead of the GPT Healthcare Q2 results\">GPT Healthcare Valuation Snapshot Ahead of the GPT Healthcare Q2 results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/gpt-healthcare-q2-results\/#What_to_Watch_in_the_GPT_Healthcare_Q2_results\" title=\"What to Watch in the GPT Healthcare Q2 results\">What to Watch in the GPT Healthcare Q2 results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/gpt-healthcare-q2-results\/#Conclusion_GPT_Healthcare_Q2_results_Outlook\" title=\"Conclusion: GPT Healthcare Q2 results Outlook\">Conclusion: GPT Healthcare Q2 results Outlook<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/gpt-healthcare-q2-results\/#FAQs\" title=\"FAQs\">FAQs<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/gpt-healthcare-q2-results\/#When_will_GPT_Healthcare_announce_its_Q2_FY27_results\" title=\"When will GPT Healthcare announce its Q2 FY27 results?\">When will GPT Healthcare announce its Q2 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/gpt-healthcare-q2-results\/#What_was_GPT_Healthcares_net_profit_in_Q1_FY27\" title=\"What was GPT Healthcare&#8217;s net profit in Q1 FY27?\">What was GPT Healthcare&#8217;s net profit in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/gpt-healthcare-q2-results\/#How_has_GPT_Healthcares_operating_margin_trended_recently\" title=\"How has GPT Healthcare&#8217;s operating margin trended recently?\">How has GPT Healthcare&#8217;s operating margin trended recently?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/gpt-healthcare-q2-results\/#What_is_GPT_Healthcares_current_valuation\" title=\"What is GPT Healthcare&#8217;s current valuation?\">What is GPT Healthcare&#8217;s current valuation?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"GPT_Healthcare_Q2_results_Date_When_Will_GPT_Healthcare_Announce_Q2_FY27_Numbers\"><\/span>GPT Healthcare Q2 results Date: When Will GPT Healthcare Announce Q2 FY27 Numbers<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>GPT Healthcare has not yet officially announced a board meeting date for the GPT Healthcare Q2 results. Based on the company&#8217;s historical reporting pattern since its listing, September-quarter results have typically been declared in the second half of October or the first two weeks of November. Investors tracking the GPT Healthcare Q2 results should watch for a formal exchange intimation of the board meeting date closer to that window.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"GPT_Healthcare_Q2_results_Expectations_Metrics_and_Trends_to_Watch\"><\/span>GPT Healthcare Q2 results Expectations: Metrics and Trends to Watch<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/premier-energies-q2-results-fy27-preview-date-expectations\">Premier Energies Q2 Results FY27 Preview<\/a><\/p>\n<p>Ahead of the GPT Healthcare Q2 results, occupancy levels across the company&#8217;s hospital beds, average revenue per occupied bed, and case mix between general and specialty treatments are the operational metrics most worth tracking. GPT Healthcare&#8217;s OPM has improved from 16.00% in Jun25 to 19.05% in Jun26, its best level in the trailing five-quarter window, even though revenue growth flattened between Mar26 and Jun26. Whether topline growth picks up again while margin holds near recent highs will likely shape how the GPT Healthcare Q2 results are read once declared.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"GPT_Healthcare_Q1_FY27_Quarter_Ended_June_2026_Previous_Quarter_Actuals\"><\/span>GPT Healthcare Q1 FY27 (Quarter Ended June 2026): Previous Quarter Actuals<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>In Q1 FY27, the quarter ended June 2026, GPT Healthcare reported revenue of Rs 126 crore, flat compared with Rs 126 crore in Mar26. Operating profit came in at Rs 24 crore with an OPM of 19.05%, its highest level in the series, up from 18.25% in Mar26. Net profit for the quarter was Rs 13 crore, moderating from Rs 15 crore in Mar26 despite the margin improvement. This is the latest actual data point ahead of the GPT Healthcare Q2 results.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"GPT_Healthcare_Q2_FY26_Quarter_Ended_September_2025_The_Base_Quarter\"><\/span>GPT Healthcare Q2 FY26 (Quarter Ended September 2025): The Base Quarter<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The year-ago quarter the GPT Healthcare Q2 results will be compared against is Q2 FY26. In that quarter, GPT Healthcare posted revenue of Rs 119 crore, operating profit of Rs 23 crore at a 19.00% OPM, and net profit of Rs 11 crore. Revenue in the Jun26 quarter is modestly higher than this base, while margin is only marginally ahead, giving a sense of the year-on-year comparison the GPT Healthcare Q2 results will eventually be measured against.<\/p>\n<p style=\"margin-top:24px\"><a href=\"https:\/\/univest.in\/open-demat-account\">Want to build a watchlist for earnings season? Open your Univest demat account today.<\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"GPT_Healthcare_Q2_results_Recent_5-Quarter_Trend\"><\/span>GPT Healthcare Q2 results: Recent 5-Quarter Trend<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tr>\n<th>Quarter<\/th>\n<th>Revenue (Rs Cr)<\/th>\n<th>OPM<\/th>\n<th>Net Profit (Rs Cr)<\/th>\n<\/tr>\n<tr>\n<td>Jun 2025<\/td>\n<td>107<\/td>\n<td>16.00%<\/td>\n<td>8<\/td>\n<\/tr>\n<tr>\n<td>Sep 2025<\/td>\n<td>119<\/td>\n<td>19.00%<\/td>\n<td>11<\/td>\n<\/tr>\n<tr>\n<td>Dec 2025<\/td>\n<td>120<\/td>\n<td>17.50%<\/td>\n<td>9<\/td>\n<\/tr>\n<tr>\n<td>Mar 2026<\/td>\n<td>126<\/td>\n<td>18.25%<\/td>\n<td>15<\/td>\n<\/tr>\n<tr>\n<td>Jun 2026<\/td>\n<td>126<\/td>\n<td>19.05%<\/td>\n<td>13<\/td>\n<\/tr>\n<\/table>\n<p>Revenue growth has slowed in the two most recent quarters after a sharper rise earlier in the series, while operating margin has stayed in a relatively narrow 16-19% band with an improving bias. This context is worth keeping in mind while reading the GPT Healthcare Q2 results once they arrive.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Factors_to_Watch_Ahead_of_the_GPT_Healthcare_Q2_results\"><\/span>Key Factors to Watch Ahead of the GPT Healthcare Q2 results<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/indiamart-intermesh-q2-results-fy27-preview-date-expectations\">Indiamart Intermesh Q2 Results FY27 Preview<\/a><\/p>\n<p>Bed occupancy rates, growth in specialty treatment volumes, and any update on new bed capacity additions across the company&#8217;s hospital network are the operational levers to track. Employee and consumable costs, which directly affect margin in a hospital business, are also worth following ahead of the GPT Healthcare Q2 results.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"GPT_Healthcare_Valuation_Snapshot_Ahead_of_the_GPT_Healthcare_Q2_results\"><\/span>GPT Healthcare Valuation Snapshot Ahead of the GPT Healthcare Q2 results<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>At the current market price of Rs 163.61, GPT Healthcare trades at a trailing PE of 28.41x, a price-to-book of 4.99x against a book value of Rs 32.8, and a return on equity of 16.7%. The stock&#8217;s 52-week range is Rs 115 to Rs 175, and it currently trades above both its 50-day moving average (Rs 151.63) and 200-day moving average (Rs 144.18), with an RSI of 75.02 pointing to overbought technical territory. The dividend yield is 1.54%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_to_Watch_in_the_GPT_Healthcare_Q2_results\"><\/span>What to Watch in the GPT Healthcare Q2 results<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Beyond the headline numbers, commentary on new hospital or bed additions, occupancy trends across existing facilities, and any change in the mix between general and specialty care will matter for the outlook beyond the September quarter. Margin sustainability near the recent 19% level is likely to be a key focus once the GPT Healthcare Q2 results are declared.<\/p>\n<p style=\"margin-top:24px\"><a href=\"https:\/\/univest.in\/open-demat-account\">Open a demat account on Univest to start tracking this counter and others like it.<\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion_GPT_Healthcare_Q2_results_Outlook\"><\/span>Conclusion: GPT Healthcare Q2 results Outlook<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>GPT Healthcare enters its reporting window with operating margin at its best level in the trailing five-quarter series, even as revenue growth has flattened over the last two quarters. The GPT Healthcare Q2 results will be watched for whether topline growth reaccelerates while margin holds firm, though actual figures can only be confirmed once the company formally reports them. This article does not offer any buy, sell or hold recommendation.<\/p>\n<p style=\"border-left:4px solid #CC0000;background:#FDECEA;padding:10px 16px;\">Univest Securities Private Limited is a SEBI-registered Research Analyst (Registration No. INH000013776). This article is for informational and educational purposes only and does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Investors should consult their own financial advisor before making any investment decision.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FAQs\"><\/span><strong>FAQs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"When_will_GPT_Healthcare_announce_its_Q2_FY27_results\"><\/span>When will GPT Healthcare announce its Q2 FY27 results?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> GPT Healthcare has not officially announced a date for its Q2 FY27 results. Based on past patterns, the company typically reports its September-quarter numbers in late October or early November.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_GPT_Healthcares_net_profit_in_Q1_FY27\"><\/span>What was GPT Healthcare&#8217;s net profit in Q1 FY27?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> In the quarter ended June 2026, GPT Healthcare reported a net profit of Rs 13 crore on revenue of Rs 126 crore, with an operating margin of 19.05%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_GPT_Healthcares_operating_margin_trended_recently\"><\/span>How has GPT Healthcare&#8217;s operating margin trended recently?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The operating margin has improved from 16.00% in June 2025 to 19.05% in June 2026, its best level across the trailing five-quarter window.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_GPT_Healthcares_current_valuation\"><\/span>What is GPT Healthcare&#8217;s current valuation?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of the latest available data, GPT Healthcare trades at a trailing PE of about 28.4 times with a return on equity of 16.7%, near the higher end of its 52-week range.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"When will GPT Healthcare announce its Q2 FY27 results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"GPT Healthcare has not officially announced a date for its Q2 FY27 results. Based on past patterns, the company typically reports its September-quarter numbers in late October or early November.\"}},{\"@type\":\"Question\",\"name\":\"What was GPT Healthcare's net profit in Q1 FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"In the quarter ended June 2026, GPT Healthcare reported a net profit of Rs 13 crore on revenue of Rs 126 crore, with an operating margin of 19.05%.\"}},{\"@type\":\"Question\",\"name\":\"How has GPT Healthcare's operating margin trended recently?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The operating margin has improved from 16.00% in June 2025 to 19.05% in June 2026, its best level across the trailing five-quarter window.\"}},{\"@type\":\"Question\",\"name\":\"What is GPT Healthcare's current valuation?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of the latest available data, GPT Healthcare trades at a trailing PE of about 28.4 times with a return on equity of 16.7%, near the higher end of its 52-week range.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>A data-backed preview of GPT Healthcare&#8217;s Q2 FY27 results covering the expected announcement window, margin trends and current valuation.<\/p>\n","protected":false},"author":29,"featured_media":254811,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5331],"tags":[5843],"class_list":["post-254812","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-https-univest-in-blogs-category-results","tag-healthcare-sector"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["254811"],"rank_math_title":["GPT Healthcare Q2 FY27 Preview: Trends and Numbers to Watch"],"rank_math_description":["GPT Healthcare Q2 results for the September 2026 quarter are due soon. Check the expected date, revenue and margin trends, and current valuation before the announcement."],"rank_math_focus_keyword":["GPT Healthcare Q2 FY27 Preview: Trends and Numbers to Watch"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/gpt-healthcare-q2-results.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/254812","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=254812"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/254812\/revisions"}],"predecessor-version":[{"id":254814,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/254812\/revisions\/254814"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/254811"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=254812"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=254812"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=254812"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}